A new classification option for NSAID hypersensitivity: Kalyoncu classification

Creative Commons License

ÖZDEMİR E., DAMADOĞLU E., KARAKAYA G., KALYONCU A. F.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.50, sa.6, ss.122-127, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.15586/aei.v50i6.693
  • Dergi Adı: ALLERGOLOGIA ET IMMUNOPATHOLOGIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, DIALNET
  • Sayfa Sayıları: ss.122-127
  • Anahtar Kelimeler: drug hypersensitivity, European Network for Drug Allergy, Kalyoncu classification, nonsteroidal anti-inflammatory drugs, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, EXACERBATED RESPIRATORY-DISEASE, PRACTICAL APPROACH, ANAPHYLAXIS, PREVALENCE, PATTERNS, ASTHMA, MANAGEMENT
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background: The European Network for Drug Allergy (ENDA) proposed a consensus document for hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in 2011. A subgroup of patients with NSAIDs-exacerbated respiratory disease (NERD) develop urticaria/ angioedema type reactions in response to NSAIDs. The Kalyoncu classification might be a novel option to classify patients with NSAID hypersensitivity (NH). In this study, we compare the ENDA and the Kalyoncu classifications.